IKBKG and immunodeficiency disease: Of note, HSCT was shown to cure immunodeficiency and susceptibility to infections in patients with NEMO deficiency, but failed to cure intestinal inflammation indicating an important role of NEMO and NF-κB signaling in controlling intestinal epithelial cell homeostasis (138).